CDK4 and neoplasm: All 17 patients included in the study exhibited CDK4 amplification, with the results of FISH analysis for the 16 evaluated patients presented in Fig. 3A. High-coverage whole-exome sequencing was performed on baseline tumor samples of 13 patients.